Structure–activity relationship study of copper(II) complexes with 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (4′-methylbenzoyl) hydrazone: synthesis, structures, DNA and protein interaction studies, antioxidative and cytotoxic activity

被引:0
作者
Duraisamy Senthil Raja
Nattamai S. P. Bhuvanesh
Karuppannan Natarajan
机构
[1] Bharathiar University,Department of Chemistry
[2] Texas A&M University,Department of Chemistry
来源
JBIC Journal of Biological Inorganic Chemistry | 2012年 / 17卷
关键词
Copper(II) complexes; DNA binding; Protein binding; Antioxidant; Cytotoxicity;
D O I
暂无
中图分类号
学科分类号
摘要
Novel 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (4′-methylbenzoyl) hydrazone (H2L) (1) and its two copper(II) complexes have been synthesized. Single-crystal X-ray diffraction studies revealed that the structure of the new copper(II) chloride complex, [Cu(H2L)Cl2]·2H2O (2), is square pyramidal and that of the copper(II) nitrate complex, [Cu(HL)NO3]·DMF (3), is square planar. In 2, the copper atom is coordinated by the ligand with ONO donor atoms, one chloride ion in the apical position, and the other chloride in the basal plane. In 3, the ligand coordinates as a uninegative tridentate ONO− species and with one nitrate ion in the basal plane. DNA binding experiments indicated that the ligand and copper(II) complexes can interact with DNA through intercalation. Bovine serum albumin binding studies revealed that the compounds strongly quench the intrinsic fluorescence of bovine serum albumin through a static quenching process. Antioxidative activity tests showed that 1 and its copper(II) complexes have significant radical scavenging activity against free radicals. Cytotoxic activities of the ligand and copper(II) complexes showed that the two copper(II) complexes exhibited more effective cytotoxic activity against HeLa and HEp-2 cells than the corresponding ligand. The entire biological activity results showed that the activity order was 1 < 2 < 3.
引用
收藏
页码:223 / 237
页数:14
相关论文
共 225 条
[1]  
Friedman AE(1991)undefined Nucleic Acids Res 19 2595-2602
[2]  
Kumar CV(1990)undefined J Am Chem Soc 112 9432-9434
[3]  
Turro NJ(2009)undefined Biochimie 91 1198-1211
[4]  
Barton JK(2008)undefined Toxicology 251 61-65
[5]  
Pyle AM(1994)undefined Acc Chem Res 27 295-301
[6]  
Morii T(1993)undefined Biochemistry 32 153-163
[7]  
Barton JK(2005)undefined Oncol Rep 14 1365-1369
[8]  
Pizarro AM(2005)undefined Nat Rev Drug Discovery 4 307-320
[9]  
Sadler PJ(2004)undefined Inorg Chem 43 8510-8519
[10]  
Raja NS(1985)undefined J Am Chem Soc 107 5518-5523